PHARMACY

Election analyst, professor Larry Sabato to address 2012 NACDS Annual Meeting

BY Antoinette Alexander

ALEXANDRIA, Va. — The National Association of Chain Drug Stores has announced that election analyst and University of Virginia professor Larry Sabato will address attendees at the 2012 NACDS Annual Meeting on April 21 to 24 in Palm Beach, Fla.

Sabato will offer remarks to NACDS Annual Meeting attendees during the business program on Sunday, April 22. 

“During this presidential and congressional election year, it is only fitting to have Larry Sabato address the attendees of the NACDS Annual Meeting,” NACDS president and CEO Steve Anderson said. “Larry’s astute election forecasting and political analyses are really second to none.  We look forward to hearing his insights and predictions for the upcoming political season.”

Sabato is the founder and head of the University of Virginia’s Center for Politics, and is the author of more than 20 book and numerous essays on politics. He also spearheads “Sabato’s Crystal Ball,” a website providing detailed and updated analysis for elections nationwide. Sabato has received multiple awards and accolades including UVA’s highest honor, the Thomas Jefferson Award, has been a guest scholar at the Brookings Institution, Oxford University and Cambridge University.

He also has served on many national and state commissions, including the National Commission for the Renewal of American Democracy and the Senate Campaign Finance Reform Panel. Sabato has appeared on various news programs and is a regular contributor to National Public Radio.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FDA approves Actavis ADHD drug

BY Alaric DeArment

MORRISTOWN, N.J. — The Food and Drug Administration has approved a generic version of a drug for attention deficit hyperactivity disorder made by Actavis, the drug maker said Wednesday.

Actavis announced the FDA approval of methylphenidate hydrochloride extended-release capsules in the 20-mg, 30-mg and 40-mg strengths, a generic version of Novartis’s Ritalin LA. Actavis said it was the first to file for regulatory approval of the drug in those three strengths, thus entitling it to 180 days of market exclusivity in which it will directly compete with the branded version.

The drug had sales of $80.7 million during the 12-month period ended in September, according to IMS Health.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Study analyzes potential benefits of MTM integration

BY Alaric DeArment

The role of the pharmacist has evolved considerably over the past decade, and few things exemplify that evolution more than pharmacists taking an active role in patients’ medication therapies and consulting with them one-on-one.


Researchers from pharmacy schools at the University of Minnesota, the University of Iowa, the University of Southern California and the University of Oklahoma collected data for “environmental scans” from U.S. MTM providers and payers using self-administered online surveys conducted between 2007 and 2010, according to a white paper published in the Journal of the American Pharmacists Association.


The study found a need to integrate MTM between organizations and patients serviced, partnering organizations and collaborating healthcare providers, as well as that “a ‘channel of distribution’ is emerging in which organizational relationships and cost efficiencies will be important considerations in the near term.” The researchers suggested that customer portfolio management and transaction cost economics would help to integrate MTM into the U.S. healthcare system.


Still, retailers across the country have embraced MTM as a way to improve medication adherence. Under a collaboration that began last year, Walgreens and Decatur, Ga.-based DeKalb Medical have the retailer’s pharmacists helping patients understand and comply with their therapies following treatment at the hospital. In November 2011, just three months after the collaboration started, the two reported that it had led to improved patient care and satisfaction.


In September 2011, Rite Aid announced that it had joined the Diabetes Prevention and Control Alliance, an initiative created by UnitedHealth Group, to have pharmacists offer diabetes consultations and MTM services to patients at several of its stores in New York and Washington.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?